Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SP100 nuclear antigen pseudogene is a noncoding segment of DNA that closely resembles the functional SP100 gene but does not produce a functional protein. Pseudogenes like this typically arise from duplication or retrotransposition events and lack the ability to encode active proteins[3]. The functional SP100 gene encodes a nuclear protein involved in chromatin organization, immune regulation, and antiviral responses[1][2][3]. However, the pseudogene variant ENSG00000270287 does not possess these properties and is not a bona fide molecular target. The entry "SP100 nuclear antigen pseudogene" (ENSG00000270287) refers to a pseudogene, not an active protein-coding gene[3]. As such, it is not considered a therapeutic target, does not have molecular functions, interacting drugs, or clinical roles. The functional gene SP100 (SP100 nuclear antigen, ENSG00000130713) is a zinc finger nuclear protein, but this is distinct from the pseudogene. Functional SP100 has roles in chromatin regulation, immune response, and is implicated in several disease processes[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SP100 nuclear antigen pseudogene.